JP2006511588A5 - - Google Patents

Download PDF

Info

Publication number
JP2006511588A5
JP2006511588A5 JP2004564285A JP2004564285A JP2006511588A5 JP 2006511588 A5 JP2006511588 A5 JP 2006511588A5 JP 2004564285 A JP2004564285 A JP 2004564285A JP 2004564285 A JP2004564285 A JP 2004564285A JP 2006511588 A5 JP2006511588 A5 JP 2006511588A5
Authority
JP
Japan
Prior art keywords
modafinil
isomer
polymorph
disorders
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004564285A
Other languages
English (en)
Japanese (ja)
Other versions
JP4719471B2 (ja
JP2006511588A (ja
Filing date
Publication date
Priority claimed from FR0216412A external-priority patent/FR2849029B1/fr
Application filed filed Critical
Publication of JP2006511588A publication Critical patent/JP2006511588A/ja
Publication of JP2006511588A5 publication Critical patent/JP2006511588A5/ja
Application granted granted Critical
Publication of JP4719471B2 publication Critical patent/JP4719471B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004564285A 2002-12-20 2003-12-18 モダフィニルの光学異性体の調製方法及び結晶形 Expired - Fee Related JP4719471B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0216412A FR2849029B1 (fr) 2002-12-20 2002-12-20 Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
FR0216412 2002-12-20
PCT/FR2003/003799 WO2004060858A1 (fr) 2002-12-20 2003-12-18 Procede de preparation et formes cristallines des enantiomeres optiques du modafinil

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011032155A Division JP5497680B2 (ja) 2002-12-20 2011-02-17 モダフィニルの異性体の調製方法及び結晶形

Publications (3)

Publication Number Publication Date
JP2006511588A JP2006511588A (ja) 2006-04-06
JP2006511588A5 true JP2006511588A5 (enExample) 2008-01-24
JP4719471B2 JP4719471B2 (ja) 2011-07-06

Family

ID=32406320

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004564285A Expired - Fee Related JP4719471B2 (ja) 2002-12-20 2003-12-18 モダフィニルの光学異性体の調製方法及び結晶形
JP2011032155A Expired - Lifetime JP5497680B2 (ja) 2002-12-20 2011-02-17 モダフィニルの異性体の調製方法及び結晶形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011032155A Expired - Lifetime JP5497680B2 (ja) 2002-12-20 2011-02-17 モダフィニルの異性体の調製方法及び結晶形

Country Status (30)

Country Link
US (10) US7132570B2 (enExample)
EP (6) EP2343275B1 (enExample)
JP (2) JP4719471B2 (enExample)
KR (1) KR101050565B1 (enExample)
CN (5) CN101654423A (enExample)
AR (1) AR042546A1 (enExample)
AU (2) AU2003299349C1 (enExample)
BR (1) BRPI0316916B1 (enExample)
CA (2) CA2510096C (enExample)
CL (2) CL2007002450A1 (enExample)
CY (1) CY1114291T1 (enExample)
DK (1) DK2343275T3 (enExample)
EA (1) EA009592B1 (enExample)
EG (1) EG24849A (enExample)
ES (3) ES2575018T3 (enExample)
FR (1) FR2849029B1 (enExample)
HK (1) HK1225371A1 (enExample)
IL (1) IL169205A (enExample)
IS (1) IS7947A (enExample)
MX (1) MXPA05006525A (enExample)
MY (1) MY142926A (enExample)
NO (1) NO335724B1 (enExample)
NZ (2) NZ540733A (enExample)
PL (1) PL377196A1 (enExample)
PT (1) PT2343275E (enExample)
SI (1) SI2343275T1 (enExample)
TW (1) TWI344952B (enExample)
UA (1) UA100964C2 (enExample)
WO (1) WO2004060858A1 (enExample)
ZA (1) ZA200504805B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077894A1 (en) * 2004-02-06 2005-08-25 Cephalon, Inc. Modafinil compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
AU2003213719A1 (en) 2002-03-01 2003-09-16 Regents Of The University Of Michigan Multiple-component solid phases containing at least one active pharmaceutical ingredient
IL165383A0 (en) 2002-06-21 2006-01-15 Transform Pharmaceuticals Inc Pharmaceutical compositions with improved dissolution
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US7521553B2 (en) 2003-03-17 2009-04-21 Hetero Drugs Limited Crystalline forms of lamotrigine
DK1610796T3 (da) * 2003-03-17 2014-07-21 Neurohealing Pharmaceuticals Inc Højpotent dopaminerg behandling af neurologisk svækkelse, som er forbundet med hjerneskade
JP4842819B2 (ja) * 2003-09-04 2011-12-21 セフアロン・インコーポレーテツド モダフィニル組成物
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
EP1516869A1 (en) 2003-09-19 2005-03-23 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US20090018202A1 (en) * 2004-02-06 2009-01-15 Cephalon, Inc. Modafinil compositions
EP2292213A1 (en) * 2004-02-06 2011-03-09 Cephalon, Inc. Compositions comprising a polymorphic form of armodafinil
JP2008506764A (ja) 2004-07-20 2008-03-06 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー ［Ｒ−（Ｒ＊，Ｒ＊）］−２−（４−フルオロフェニル）−β、δ−ジヒドロキシ−５−（１−メチルエチル）−３−フェニル−４−［（フェニルアミノ）カルボニル］−１Ｈ−ピロール−１−ヘプタン酸カルシウム塩（２：１）の新規形態
US20060086667A1 (en) * 2004-09-13 2006-04-27 Cephalon, Inc., U.S. Corporation Methods for the separation of enantiomeric sulfinylacetamides
EP1702915A1 (en) 2005-03-14 2006-09-20 Cephalon France Process for enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation
AU2006272874B2 (en) * 2005-07-21 2010-03-11 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
MX2007012605A (es) * 2006-02-21 2008-01-11 Teva Pharma Formas cristalinas novedosas de armodafinil y preparacion de ellas.
CA2634133A1 (en) 2006-03-01 2007-09-13 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of armodafinil
AU2007272501A1 (en) * 2006-07-12 2008-01-17 Elan Pharma International Limited Nanoparticulate formulations of modafinil
WO2008021341A2 (en) * 2006-08-14 2008-02-21 Neurohealing Pharmaceuticals, Inc. Modafinil-based treatment for premature ejaculation
US20080214862A1 (en) * 2006-12-06 2008-09-04 Ben-Zion Dolitzky Processes for preparing armodafinil intermediate
US20100010092A1 (en) * 2006-12-19 2010-01-14 Arless Ltd. Use of modafinil to treat restless leg syndrome
US20100234468A1 (en) * 2007-06-04 2010-09-16 Abhay Gaitonde Novel process
WO2009024863A2 (en) * 2007-06-26 2009-02-26 Actavis Group Ptc Ehf Process for the preparation of modafinil enantiomers
WO2009025791A2 (en) * 2007-08-16 2009-02-26 Teva Pharmaceutical Industries Ltd. Purification of armodafinil
US20090082462A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched armodafinil
WO2009045488A2 (en) * 2007-10-02 2009-04-09 Teva Pharmaceutical Industries Ltd. Novel crystalline forms of armodafinil and preparation thereof
WO2009090663A1 (en) * 2008-01-15 2009-07-23 Lupin Limited Novel crystalline polymorph of armodafinil and an improved process for preparation thereof
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
US20100036164A1 (en) * 2008-08-06 2010-02-11 Srinivas Areveli Preparation of armodafinil form i
EP2292306B1 (en) 2009-09-02 2013-05-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for separation of racemic compound-forming chiral substances by a cyclic crystallization process and a crystallization device
US20130085304A1 (en) * 2009-11-19 2013-04-04 Ranbaxy Laboratories Limited Processes for preparation of polymorphic forms of lacosamide
CN102781446A (zh) * 2010-01-07 2012-11-14 维瓦斯公司 采用碳酸酐酶抑制剂和另外的活性剂的组合治疗阻塞性睡眠呼吸暂停综合征
EP2649187B1 (en) 2010-12-08 2017-11-22 Codexis, Inc. Biocatalysts and methods for the synthesis of armodafinil
JP6116847B2 (ja) * 2012-10-01 2017-04-19 アムビト バイオサイエンシス コーポレーションＡｍｂｉｔ Ｂｉｏｓｃｉｅｎｃｅｓ Ｃｏｒｐｏｒａｔｉｏｎ シクロデキストリンとの混合体を含有する錠剤
US10466776B2 (en) * 2014-06-24 2019-11-05 Paypal, Inc. Surfacing related content based on user interaction with currently presented content
US10326922B2 (en) * 2014-07-23 2019-06-18 Orcam Technologies Ltd. Wearable apparatus and method for capturing image data using multiple image sensors
CN107000038A (zh) * 2014-11-27 2017-08-01 株式会社Gc 蜡模的表面处理剂以及制造牙科假体的方法
WO2017064723A1 (en) * 2015-10-12 2017-04-20 Natco Pharma Ltd An improved process for the preparation of armodafinil

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1905990A (en) 1931-01-02 1933-04-25 Hoffmann La Roche Disubstituted carbamic acid esters of phenols containing a basic constituent
GB1197809A (en) 1968-02-13 1970-07-08 Inst Noguchi Method for Continuous Optical Resolution of Organic Racemates.
GB1584462A (en) 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2593809B1 (fr) 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2597864B1 (fr) 1986-04-28 1990-11-16 Lafon Labor Nouveaux derives de la n-((trimethoxy-2,4,6-benzoyl)-3 propyl) piperidine, leurs procedes de preparation et leur application en therapeutique
FR2626881B1 (fr) 1988-02-10 1990-07-27 Lafon Labor 1-(4-aminophenyl)-2-hexamethyleneiminopropanone, procede de preparation et utilisation en therapeutique
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2671349B1 (fr) 1991-01-09 1993-04-23 Lafon Labor Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.
FR2710337B1 (fr) * 1993-09-23 1995-12-08 Gerard Coquerel Procédé de dédoublement de deux antipodes optiques par entraînement polythermique programmé et autoensemencé.
US6894171B1 (en) 1998-07-20 2005-05-17 Abbott Laboratories Polymorph of a pharmaceutical
CN1249932A (zh) 1999-09-29 2000-04-12 付俊昌 一种莫达芬尼及其光学对映体l及d异构体的新用途
EP1248869A2 (en) 2000-01-07 2002-10-16 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
US20010036640A1 (en) 2000-04-25 2001-11-01 D'amico Kevin L. System and methods for the high throughput screening of polymorphs
US6670358B2 (en) 2000-05-16 2003-12-30 Cephalon, Inc. Substituted thioacetamides
US6492396B2 (en) * 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
DE10025756C2 (de) * 2000-05-25 2003-02-20 Cognis Deutschland Gmbh Lösungsvermittler
WO2005077894A1 (en) 2004-02-06 2005-08-25 Cephalon, Inc. Modafinil compositions
ES2277937T3 (es) * 2000-07-27 2007-08-01 Teva Pharmaceutical Industries Ltd. Modafinilo puro y cristalino y su procedimiento de preparacion.
US6835307B2 (en) * 2000-08-04 2004-12-28 Battelle Memorial Institute Thermal water treatment
US6489363B2 (en) 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US6919378B2 (en) 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
KR100704213B1 (ko) 2000-11-03 2007-04-10 테바 파마슈티컬 인더스트리즈 리미티드 아토르바스타틴 헤미-칼슘 ｖｉｉ형
US7297346B2 (en) 2001-05-25 2007-11-20 Cephalon Inc. Pharmaceutical formulations of modafinil
US20030119060A1 (en) 2001-08-10 2003-06-26 Desrosiers Peter J. Apparatuses and methods for creating and testing pre-formulations and systems for same
EP1466166B2 (en) 2002-01-15 2013-05-01 Avantium International B.V. Method for performing powder diffraction analysis
US6875893B2 (en) * 2002-05-23 2005-04-05 Cephalon, Inc. Preparations of a sulfinyl acetamide
US7229644B2 (en) 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
EP1525049B1 (en) 2002-08-02 2007-07-04 Avantium International B.V. An assembly and method for performing parallel chemical experiments, in particular crystallisation experiments
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
EP1567497B1 (en) 2002-12-06 2009-09-23 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
NZ545133A (en) 2003-09-04 2009-12-24 Cephalon Inc Modafinil compositions
US7566805B2 (en) * 2003-09-04 2009-07-28 Cephalon, Inc. Modafinil compositions
US20090018202A1 (en) * 2004-02-06 2009-01-15 Cephalon, Inc. Modafinil compositions
KR100872675B1 (ko) 2004-10-13 2008-12-10 파마시아 앤드 업존 캄파니 엘엘씨 3-[5-클로로-4-[(2,4-디플루오로벤질)옥시]-6-옥소피리미딘-1(6ｈ)-일]-ｎ-(2-히드록시에틸)-4-메틸벤즈아미드의결정형
AU2006272874B2 (en) * 2005-07-21 2010-03-11 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
MX2007012605A (es) * 2006-02-21 2008-01-11 Teva Pharma Formas cristalinas novedosas de armodafinil y preparacion de ellas.
CA2634133A1 (en) 2006-03-01 2007-09-13 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of armodafinil
US20100234468A1 (en) 2007-06-04 2010-09-16 Abhay Gaitonde Novel process
WO2009024863A2 (en) 2007-06-26 2009-02-26 Actavis Group Ptc Ehf Process for the preparation of modafinil enantiomers
WO2009025791A2 (en) 2007-08-16 2009-02-26 Teva Pharmaceutical Industries Ltd. Purification of armodafinil
WO2009045488A2 (en) 2007-10-02 2009-04-09 Teva Pharmaceutical Industries Ltd. Novel crystalline forms of armodafinil and preparation thereof
EP1911739A3 (en) * 2007-11-05 2008-09-17 Dipharma Francis S.r.l. Crystalline form of (S)-2-phenylethylammonium (R)-diphenyl-methanesulphinyl-acetate
WO2009090663A1 (en) 2008-01-15 2009-07-23 Lupin Limited Novel crystalline polymorph of armodafinil and an improved process for preparation thereof

Similar Documents

Publication Publication Date Title
JP2006511588A5 (enExample)
JP5497680B2 (ja) モダフィニルの異性体の調製方法及び結晶形
AU2008253696B2 (en) Formoterol tartrate process and polymorph
JP4575337B2 (ja) アゴメラチンの新規な結晶形態ｖ、その製造方法、およびそれを含有する薬学的組成物
JP2009531358A (ja) 改良された結晶性物質
JP2018024636A (ja) ［（２ｒ，３ｓ，４ｒ，５ｒ）−５−（６−（シクロペンチルアミノ）−９ｈ−プリン−９−イル）−３，４−ジヒドロキシテトラヒドロフラン−２−イル］メチルナイトレートの無水多形体及びその製造方法
JP7012725B2 (ja) アセチルサリチル酸リジン・グリシン粒子の改良された合成
JP6908657B2 (ja) ４−［２−ジメチルアミノ−１−（１−ヒドロキシシクロヘキシル）エチル］フェニル４−メチルベンゾエートヒドロクロリドの多形体、それらを作製する方法及びそれらの使用
CN109689620A (zh) 拆分巴氯芬盐的方法
HK1078309B (en) Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil
HK1192221A (en) Preparation methods of crystalline forms of optical enantiomers of modafinil and pharmaceutical composition thereof
HK1192218A (en) Preparation method and crystalline form iv of optical enantiomers of modafinil
HK1078309A (en) Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil
HK1192222B (en) Preparation method and crystalline form of optical enantiomers of modafinil